RPGLIFE — RPG Life Sciences Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual income statement for RPG Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,891	4,402	5,128	5,821	6,534
Cost of Revenue
Gross Profit	2,402	2,773	3,283	3,735	4,119
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,357	3,695	4,248	4,710	4,326
Operating Profit	535	707	880	1,111	2,208
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	536	732	917	1,178	2,329
Provision for Income Taxes
Net Income After Taxes	400	515	676	877	1,832
Net Income Before Extraordinary Items
Net Income	400	515	676	877	1,832
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	400	515	676	877	1,832
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	24.2	31.1	41.2	53	70.9
Dividends per Share
Special Dividends per Share